2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
6
Genitourinary
5
Gynecologic
3
Thoracic
2
Conditions
Carcinoma, Non-Small-Cell Lung
6874
Lung Neoplasms
5105
Small Cell Lung Carcinoma
1166
Breast Neoplasms
855
Neoplasms
762
Colorectal Neoplasms
670
Melanoma
566
Ovarian Neoplasms
506
Neoplasm Metastasis
481
Pancreatic Neoplasms
473
Adenocarcinoma of Lung
398
Stomach Neoplasms
396
Prostatic Neoplasms
370
Head and Neck Neoplasms
368
Carcinoma, Renal Cell
350
Esophageal Neoplasms
337
Squamous Cell Carcinoma of Head and Neck
325
Mesothelioma, Malignant
324
Colonic Neoplasms
294
Mesothelioma
289
Urinary Bladder Neoplasms
262
Brain Neoplasms
254
Uterine Cervical Neoplasms
243
Triple Negative Breast Neoplasms
223
Sarcoma
198
Endometrial Neoplasms
196
Carcinoma, Hepatocellular
186
NSCLC
167
Pleural Effusion, Malignant
160
Kidney Neoplasms
160
Interventions
Tamsulosin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Urinary Retention
×
Thoracic
×
Clear all
NCT03609580
2025-10-24
POUR
Hackensack Meridian Health
Phase 1/2
Recruiting
127 enrolled
NCT02640326
2018-12-21
UCATh
McMaster University
Phase NA
Withdrawn